Phathom Pharmaceuticals (PHAT) Revenue & Revenue Breakdown
Phathom Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$175.11M
Latest Revenue (Q)
$84.72M
Phathom Pharmaceuticals Revenue by Period
Phathom Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $175.11M | 216.93% |
| 2024-12-31 | $55.25M | 8001.47% |
| 2023-12-31 | $682.00K | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Phathom Pharmaceuticals generated $175.11M in revenue during NA 2025, up 216.93% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Phathom Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-09-30 | $84.72M | 14.07% |
| 2026-06-30 | $74.27M | 27.40% |
| 2026-03-31 | $58.30M | 1.25% |
| 2025-12-31 | $57.58M | 16.32% |
| 2025-09-30 | $49.50M | 25.32% |
| 2025-06-30 | $39.50M | 38.51% |
| 2025-03-31 | $28.52M | -3.86% |
| 2024-12-31 | $29.66M | 81.41% |
| 2024-09-30 | $16.35M | 123.27% |
| 2024-06-30 | $7.32M | 283.05% |
| 2024-03-31 | $1.91M | 180.35% |
| 2023-12-31 | $682.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | - |
Phathom Pharmaceuticals generated $84.72M in revenue during Q3 2026, up 14.07% compared to the previous quarter, and up 214.47% compared to the same period a year ago.
Phathom Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ARDX | Ardelyx | $407.32M | $120.88M |
| PHAT | Phathom Pharmaceuticals | $175.11M | $84.72M |